Skip to main content
Log in

Changes of serum prostate-specific antigen following high energy thick loop prostatectomy

  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

We evaluated the effect of the high electrocuting energy used with thethick loop, in transurethral vaporization resection of the prostate (TUVRP),on serum prostate-specific antigen (PSA). Forty-eight patients with benignprotatic hyperplasia (BPH) were included in this prospective single armsequential study. All patients had TUVRP using the `Wing' thick resectionelectrode (Richard Wolf, Germany). Serum PSA was measured before, 1 dayand 6 weeks in the morning post TUVRP. PSA values were correlated topreoperative prostate size and to prostatic resection weight. Serum PSAvalues (mean ± SD) were 6.29 ± 4.4 ng/ml, 14.9 ± 11.1 and 2.3 ± 1.9 before, 1 day and 6 weeks post TUVRP respectively. The mean increase in the PSA at 1 day over baseline value was 2.72, this wasstatistically significant (p ≤ 0.0001). The PSA level returned toless than pre TUVRP value in all but 3 patients by 6 weeks. The PSA value1 day post TUVRP correlated well with the pre PSA level, prostate size andprostatic resection weight (r = 0.58, r = 0.38 and r = 0.44 respectively) however, the PSA level at 6 weeks correlated only to pre TUVRP values (r = 0.53). We conclude that that serum PSA is not reliable within 6 weeks of TUVRP. The reversible increase in serum PSA value is similar to other forms of prostatectomy which, suggests that the increased level of electrosurgical energy that is used in TUVRP does not have an added adverse effect on the PSA levels.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Oesterling JE. Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J Urol 1991; 145: 907.

    PubMed  CAS  Google Scholar 

  2. Partin AW, Oesterling JE. The clinical usefulness of prostate specific antigen. Update 1994. J Urol 1994; 152: 1358.

    PubMed  CAS  Google Scholar 

  3. Pollen JJ, Dreilinger A. Immunohistochemical identification of prostatic acid phosphatase and prostate specific antigen in female periurethral glands. Urology 1984; 23: 303.

    Article  PubMed  CAS  Google Scholar 

  4. Polascik TJ, Oesterling JE, Partin AW. Prostate specific antigen: a decade of discovery-what we have learned and where we are going. J Urol 1999; 162: 293.

    Article  PubMed  CAS  Google Scholar 

  5. Oesterling JE. Prostate specific antigen: Improving its ability to diagnose early prostate cancer. JAMA 1992; 267: 2236.

    Article  PubMed  CAS  Google Scholar 

  6. Yan JJJ, Coplen DE, Petros JA, Figenshau RS, Radiff RL, Smith DS, Catalona WJ. Effects of rectal examination, prostatic message, ultrasonography, and needle biopsy on serum prostate specific antigen levels. J Urol 1992; 147: 810.

    Google Scholar 

  7. Oesterling JE, Rice DC, Glenski WJ, Bergstralh EJ. Effects of cystoscopy, prostate biopsy, and transurethral resection of the prostate serum prostate specific antigen concentraton. Urology 1993; 42: 276.

    Article  PubMed  CAS  Google Scholar 

  8. Vesey SG, Goble NM, Stower MJ, Hammonds JC, Smoith PJB. The effects of transurethral prostatectomy on serum prostate specific antigen. Br J Urol 1988; 62: 347.

    Article  PubMed  CAS  Google Scholar 

  9. Kupeli S, Soygur T, Yilmaz E, Aytac S. Effect of transurethral electrovaporization of the prostate on serum prostate specific antigen concentration. BJU International 1999; 83: 783.

    Article  PubMed  CAS  Google Scholar 

  10. Kosar A, Sarica K, Ozdiler E, Budak M, Dincel C, Gogus O. Effects of laser prostatectomy on the serum prostate specific antigen concentraton: results of a prospective study. Eur Urol 1998; 34: 193.

    Article  PubMed  CAS  Google Scholar 

  11. Talic RF. Transurethral electrovaporization-resection of the prostate using the ‘Wing’ cutting electrode: preliminary results of safety and efficacy in the treatment of men with prostatic outflow obstruction. Urology 1999; 53: 106.

    Article  PubMed  CAS  Google Scholar 

  12. Perlmutter AP, Schulsinger DA. The Wedge resection device for electrosurgical transurethral prostatectomy. J Endourology 1998; 12: 75.

    Article  CAS  Google Scholar 

  13. Aus G, Bergdhal S, Frosing R, Lodding P, Pileblad E, Hugosson J. Reference range of prostate specific antigen after transurethral resection of the prostate. Urology 1996; 47: 529.

    Article  PubMed  CAS  Google Scholar 

  14. Deliveliotis C, Alivizatos G, Stavrapoulos NJ, Makrychoritis K, Koutsokalis G, Kiriakakis Z, Kostakopoulos A, Dimopoulos C. Influence of digital examination, cystoscopy, transrectal ultrasonography and needle biopsy on the concentration of prostate specific antigen. Urol Int 1994; 53: 186.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Talic, R., El-Tiraifi, AM., Altaf, S. et al. Changes of serum prostate-specific antigen following high energy thick loop prostatectomy. Int Urol Nephrol 32, 271–274 (2000). https://doi.org/10.1023/A:1007170029017

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1007170029017

Navigation